Literature DB >> 11897715

Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.

Roy E Weiss1, Martine Gehin, Jianming Xu, Peter M Sadow, Bert W O'Malley, Pierre Chambon, Samuel Refetoff.   

Abstract

Steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF)-2 are homologous nuclear receptor coactivators. We have investigated their possible redundancy as thyroid hormone (TH) coactivators by measuring thyroid function in compound SRC-1 and TIF-2 knock out (KO) mice. Whereas SRC-1 KO (SRC-1(-/-)) mice are resistant to TH and SRC-1(+/-) are not, we now demonstrate that TIF-2 KO (TIF-2(-/-)) mice have normal thyroid function. Yet double heterozygous, SRC-1(+/-)/TIF-2(+/-) mice manifested resistance to TH of a similar degree as that in mice completely deficient in SRC-1. KO of both SRC-1 and TIF-2 resulted in marked increases of serum TH and thyrotropin concentrations. This work demonstrates gene dosage effect in nuclear coactivators manifesting as haploinsufficiency and functional redundancy of SRC-1 and TIF-2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897715     DOI: 10.1210/endo.143.4.8828

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia.

Authors:  Kathrin Müller; Dagmar Führer; Jens Mittag; Nora Klöting; Matthias Blüher; Roy E Weiss; Marie-Christine Many; Kurt Werner Schmid; Knut Krohn
Journal:  Mol Endocrinol       Date:  2011-10-06

2.  Mediator subunit MED1 is a T3-dependent and T3-independent coactivator on the thyrotropin β gene promoter.

Authors:  Keiji Matsui; Kasumi Oda; Shumpei Mizuta; Ruri Ishino; Norinaga Urahama; Natsumi Hasegawa; Robert G Roeder; Mitsuhiro Ito
Journal:  Biochem Biophys Res Commun       Date:  2013-09-18       Impact factor: 3.575

Review 3.  Thyroid hormone actions in cartilage and bone.

Authors:  Graham R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

4.  Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.

Authors:  Kristen R Vella; Preeti Ramadoss; Ricardo H Costa-E-Sousa; Inna Astapova; Felix D Ye; Kaila A Holtz; Jamie C Harris; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

5.  Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.

Authors:  Manuel Mark; Hiromi Yoshida-Komiya; Martine Gehin; Lan Liao; Ming-Jer Tsai; Bert W O'Malley; Pierre Chambon; Jianming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 6.  The actions of thyroid hormone signaling in the nucleus.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Mol Cell Endocrinol       Date:  2017-03-10       Impact factor: 4.102

Review 7.  Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain.

Authors:  Thierry D Charlier; Charlotte A Cornil; Gregory F Ball; Jacques Balthazart
Journal:  Biochim Biophys Acta       Date:  2010-01-12

8.  The thyrotropin-releasing hormone gene is regulated by thyroid hormone at the level of transcription in vivo.

Authors:  Michelle L Sugrue; Kristen R Vella; Crystal Morales; Marisol E Lopez; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-12-23       Impact factor: 4.736

9.  Obesity Due to Steroid Receptor Coactivator-1 Deficiency Is Associated With Endocrine and Metabolic Abnormalities.

Authors:  Tessa M Cacciottolo; Elana Henning; Julia M Keogh; Pierre Bel Lassen; Katherine Lawler; Rebecca Bounds; Rachel Ahmed; Aliki Perdikari; Edson Mendes de Oliveira; Miriam Smith; Edmund M Godfrey; Elspeth Johnson; Leanne Hodson; Karine Clément; Agatha A van der Klaauw; I Sadaf Farooqi
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.